You are not logged in.
This means you
CAN ONLY VIEW reports that were published prior to Saturday, September 7, 2024.
You
MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.
AFTER MARKET UPDATE - TUESDAY, MARCH 24TH, 2015
Previous After Market Report Next After Market Report >>>
|
|
|
|
DOW |
-104.90 |
18,011.14 |
-0.58% |
|
Volume |
733,813,840 |
+2% |
|
Volume |
1,495,399,990 |
+3% |
|
NASDAQ |
-16.24 |
4,994.73 |
-0.32% |
|
Advancers |
1,331 |
42% |
|
Advancers |
1,306 |
46% |
|
S&P 500 |
-12.92 |
2,091.50 |
-0.61% |
|
Decliners |
1,717 |
54% |
|
Decliners |
1,457 |
51% |
|
Russell 2000 |
-1.25 |
1,263.46 |
-0.10% |
|
52 Wk Highs |
110 |
|
|
52 Wk Highs |
116 |
|
|
S&P 600 |
+0.15 |
728.01 |
+0.02% |
|
52 Wk Lows |
17 |
|
|
52 Wk Lows |
27 |
|
|
 |
Major Averages Erased Early Gains to End Session Lower
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
The major averages gave up modest early gains to end the session lower on Tuesday. The Dow declined 105 points to 18,011. The S&P 500 was down 13 points to 2,091. The NASDAQ Composite fell 16 points to 4,994. The volume totals were reported higher on the NYSE and on the Nasdaq exchange versus the prior session totals, a sign of distributional pressure. Decliners led advancers by an 8-7 margin on the NYSE and by a narrower margin on the Nasdaq exchange. There were 63 high-ranked companies from the CANSLIM.net Leaders List that made new 52-week highs and appeared on the CANSLIM.net BreakOuts Page, down from the prior session total of 108 stocks. The list of new 52-week highs contracted yet still outnumbered new 52-week lows on the NYSE and on the Nasdaq exchange. There were gains for only 3 of the 13 high-ranked companies currently on the Featured Stocks Page.
Concerning the M criteria, the major averages' uptrend has been supported by a healthy crop of stocks hitting new highs. Recent expansion in leadership was an encouraging sign for the market outlook. New buying efforts should only be made in stocks meeting all of the fundamental and technical guidelines the fact-based investment system.
PICTURED: The S&P Small Cap 600 Index is hitting new all-time highs with a recent streak of gains.
The major averages finished firmly in negative territory as investor attention remained on the Fed. In a speech in Sydney, Australia, San Francisco President John Williams said the central bank should begin discussing raising rates by midyear. On the economic front, reports showed consumer prices rose 0.2% and new home sales unexpectedly climbed 7.8% in February.
Tuesday's retreat was broad based with all 10 sectors down on the session. PG&E (PCG -1.89%) was lower while utilities and health care were the worst performing groups.. Biogen (BIIB -2.38%) was lower to extend its pullback to a second day. Financials also weighed on the market with J.P Morgan Chase & Co (JPM -1.11%) down. McCormick (MKC +2.62%) was a notable gainer after the spice maker posted earnings above projections. Netflix (NFLX +3.12%) rose following positive analyst comments on the shares.
Treasuries rose as this morning's inflation reading prompted speculation the Fed will delay raising interest rates this year. U.S. government debt also advanced amid strong demand at the latest $26 billion two-year note auction. Benchmark 10-year notes were up 13/32 to yield 1.87%.
In commodities, NYMEX WTI crude slipped 0.1% to $47.41/barrel. COMEX gold gained 0.5% to $1,193.30/ounce.
The Featured Stocks Page shows recent notes and Headline Links directing members to detailed analysis with data-packed graphs annotated by a Certified expert. See the Premium Member Homepage for archives to all prior pay reports published.
|
Kenneth J. Gruneisen started out as a licensed stockbroker in August 1987, a couple of months prior to the historic stock market crash that took the Dow Jones Industrial Average down -22.6% in a single day. He has published daily fact-based fundamental and technical analysis on high-ranked stocks online for two decades. Through FACTBASEDINVESTING.COM, Kenneth provides educational articles, news, market commentary, and other information regarding proven investment systems that work in good times and bad.
Comments contained in the body of this report are technical opinions only and are not necessarily those of Gruneisen Growth Corp. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. Our firm, employees, and customers may effect transactions, including transactions contrary to any recommendation herein, or have positions in the securities mentioned herein or options with respect thereto. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. |
|
 |
Financial, Tech, and Commodity-Linked Groups Fell
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
Weakness in financial shares weighed on the major averages on Tuesday as the Bank Index ($BKX -0.91%) and the Broker/Dealer Index ($XBD -0.62%) both suffered modest losses. The tech sector saw unanimous losses for the Semiconductor Index ($SOX -0.85%), Networking Index ($NWX -0.84%), and the Biotechnology Index ($BTK -0.81%). The Retail Index ($RLX +0.05%) finished flat. Losses in commodity-linked groups rounded out the mostly negative session as the Gold & Silver Index ($XAU -0.35%), Integrated Oil Index ($XOI -0.78%), and the Oil Services Index ($OSX -0.21%) all ended lower.
Charts courtesy www.stockcharts.com
PICTURED: The Broker/Dealer Index ($XBD -0.62%) is consolidating near all-time highs.
| Oil Services |
$OSX |
187.55 |
-0.39 |
-0.21% |
-11.06% |
| Integrated Oil |
$XOI |
1,314.63 |
-10.31 |
-0.78% |
-2.49% |
| Semiconductor |
$SOX |
717.78 |
-6.18 |
-0.85% |
+4.50% |
| Networking |
$NWX |
372.38 |
-3.15 |
-0.84% |
+4.03% |
| Broker/Dealer |
$XBD |
189.99 |
-1.18 |
-0.62% |
+2.90% |
| Retail |
$RLX |
1,129.62 |
+0.61 |
+0.05% |
+9.38% |
| Gold & Silver |
$XAU |
70.56 |
-0.25 |
-0.35% |
+2.59% |
| Bank |
$BKX |
72.70 |
-0.67 |
-0.91% |
-2.10% |
| Biotech |
$BTK |
4,119.97 |
-33.46 |
-0.81% |
+19.80% |
|
|
|
 |
Fundamental Concerns Raised by Weaker Earnings and Sales Increases
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
Valeant Pharmaceuticals International, Inc. (VRX -$0.74% or -0.36% to $202.61) completed a new Public Offering on 3/17/15 while consolidating near its all-time high, very extended from any sound base. It completed an earlier Public Offering on 6/18/13. The upshot of such offerings is that the end result is typically an increase in the total number of institutional owners. Unfortunately, VRX's latest earnings for Dec '14 quarter raised fundamental concerns for fans of the fact-based investment system.
Its 50-day moving average (DMA) line ($178.90) defines the closest support to watch. The high-ranked Medical - Ethical Drugs firm was last shown in this FSU section on 3/03/15 with annotated daily and weekly graphs under the headline, "Extended From Sound Base; Earnings Below +25% Raised Concerns". It gapped up on 2/23/15 for a considerable volume-driven gain on news it will acquire Salix Pharmaceuticals (SLXP). Following that big gap up gain, however, on 2/24/15 VRX reported earnings for the Dec '14 quarter +20%. That was below the +25% minimum guideline of the fact-based system (C criteria), raising fundamental concerns.
It traded up as much as +42.8% since highlighted at $144.84 in yellow in the 1/05/15 mid-day report (read here) with an annotated weekly graph showing a new pivot point cited based on the 12/22/14 high while building a cup-with-handle base. Subsequent gains above the pivot point on 1/08/15 were backed by +71% above average volume triggering a new technical buy signal.
A downturn in FY '07 and '08 earnings (A criteria) was followed by a strong earnings rebound in recent years. Its current Up/Down Volume Ratio of 1.6 is an unbiased indication its shares have been under accumulation over the past 50 days. The number of top-rated funds owning its shares rose from 1,056 in Mar '14 to 1,166 in Dec '14, a reassuring trend concerning the I criteria.
|
|
|
Color Codes Explained :
Y - Better candidates highlighted by our
staff of experts.
G - Previously featured
in past reports as yellow but may no longer be buyable under the
guidelines.
***Last / Change / Volume data in this table is the closing quote data***
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE
(%Change) |
Day High |
Volume
(% DAV)
(% 50 day avg vol) |
52 Wk Hi
% From Hi |
Featured
Date |
Price
Featured |
Pivot Featured |
|
Max Buy |
ACT
-
NYSE
Actavis plc
Medical-Generic Drugs
|
$309.13
|
-5.84
-1.85% |
$316.93
|
3,269,983
97.82% of 50 DAV
50 DAV is 3,343,000
|
$317.72
-2.70%
|
12/29/2014
|
$260.22
|
PP = $272.85
|
|
MB = $286.49
|
Most Recent Note - 3/23/2015 5:51:45 PM
G - Pulled back from its 52-week high with a small loss on average volume following a streak of 8 consecutive gains. It is very extended from any sound base. Completed a new Public Offering on 2/25/15. Reported Dec '14 earnings +23%, below the +25% minimum guideline (C criteria) of the fact-based investment system. Its 50 DMA line defines support where violations would raise more serious concerns.
>>> FEATURED STOCK ARTICLE : Extended From Base After Completing New Public Offering - 3/13/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
AKAM
-
NASDAQ
Akamai Technologies Inc
INTERNET - Internet Software and Services
|
$72.61
|
-0.53
-0.72% |
$73.42
|
891,196
52.80% of 50 DAV
50 DAV is 1,688,000
|
$73.53
-1.25%
|
2/13/2015
|
$68.46
|
PP = $65.49
|
|
MB = $68.76
|
Most Recent Note - 3/23/2015 5:32:26 PM
G - Following brief consolidation gains lacked great volume conviction. Prior highs in the $65 area and its 50 DMA line define important support to watch on pullbacks. See latest FSU analysis for more details and new annotated graphs.
>>> FEATURED STOCK ARTICLE : Wedging Gains Have Followed Brief Consolidation - 3/23/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
AMBA
-
NASDAQ
Ambarella Inc
ELECTRONICS - Semiconductor - Specialized
|
$72.72
|
+0.47
0.65% |
$73.47
|
933,877
47.31% of 50 DAV
50 DAV is 1,974,000
|
$73.50
-1.06%
|
3/2/2015
|
$60.54
|
PP = $63.30
|
|
MB = $66.47
|
Most Recent Note - 3/24/2015 5:15:30 PM
G - Perched well above its "max buy" level, and disciplined investors avoid chasing stocks more than +5% above their pivot point. Prior highs near $63 define important near term support to watch on pullbacks.
>>> FEATURED STOCK ARTICLE : Rallied Above Max Buy Level Following Strong Earnings News - 3/10/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
EPAM
-
NYSE
Epam Systems Inc
COMPUTER SOFTWARE and SERVICES - Information Technology Service
|
$61.95
|
-0.74
-1.18% |
$62.89
|
231,644
65.81% of 50 DAV
50 DAV is 352,000
|
$63.50
-2.44%
|
2/5/2015
|
$51.39
|
PP = $52.99
|
|
MB = $55.64
|
Most Recent Note - 3/23/2015 5:47:24 PM
G - Rallied with above average volume behind today's gain for a best-ever close. Held its ground after getting extended from the prior base. Prior highs and its 50 DMA line define support to watch on pullbacks.
>>> FEATURED STOCK ARTICLE : Hovering Near Highs Extended From Prior Base - 3/18/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
FB
-
NASDAQ
Facebook Inc Cl A
INTERNET
|
$85.31
|
+0.88
1.04% |
$86.07
|
32,493,942
123.72% of 50 DAV
50 DAV is 26,264,000
|
$84.96
0.41%
|
2/20/2015
|
$81.79
|
PP = $78.47
|
|
MB = $82.39
|
Most Recent Note - 3/23/2015 5:54:39 PM
G - Hit another new 52 week high with today's 6th consecutive gain, recently rallying clear of all resistance due to overhead supply. Its Relative Strength rating has improved to 82, above the 80+ minimum guideline for new buy candidates.
>>> FEATURED STOCK ARTICLE : Relative Strength Rating Fell While Encountering Resistance - 3/11/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE
(%Change) |
Day High |
Volume
(% DAV)
(% 50 day avg vol) |
52 Wk Hi
% From Hi |
Featured
Date |
Price
Featured |
Pivot Featured |
|
Max Buy |
ILMN
-
NASDAQ
Illumina Inc
DRUGS - Biotechnology
|
$190.91
|
-1.19
-0.62% |
$195.10
|
1,019,931
85.81% of 50 DAV
50 DAV is 1,188,600
|
$213.33
-10.51%
|
12/30/2014
|
$186.26
|
PP = $196.00
|
|
MB = $205.80
|
Most Recent Note - 3/23/2015 5:42:23 PM
G - Slumped back below its 50 DMA line with a loss today below average volume. Color code is changed to green as its Relative Strength rating has slumped to 75, below the 80+ minimum guideline for buy candidates.
>>> FEATURED STOCK ARTICLE : Found Support at 50-Day Moving Average Line But Relative Strength Has Slumped - 3/5/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
JLL
-
NYSE
Jones Lang Lasalle Inc
REAL ESTATE - Property Management/Developmen
|
$165.77
|
-2.88
-1.71% |
$169.03
|
355,217
119.20% of 50 DAV
50 DAV is 298,000
|
$170.85
-2.97%
|
2/3/2015
|
$156.95
|
PP = $154.66
|
|
MB = $162.39
|
Most Recent Note - 3/23/2015 5:44:33 PM
G - Touched a new high today but ended with a small loss, and it is extended from its prior base following 5 consecutive gains. Its 50 DMA line recently acted as support.
>>> FEATURED STOCK ARTICLE : Found Support Near Prior Highs and 50-Day Moving Average Line - 3/17/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
LNKD
-
NYSE
Linkedin Corp Class A
INTERNET - Internet Information Providers
|
$264.16
|
+2.32
0.89% |
$267.28
|
1,108,438
71.05% of 50 DAV
50 DAV is 1,560,000
|
$276.18
-4.35%
|
2/6/2015
|
$269.83
|
PP = $243.35
|
|
MB = $255.52
|
Most Recent Note - 3/23/2015 5:55:49 PM
G - Small loss today on light volume while consolidating above its 50 DMA line. Stalled and made no progress since the considerable "breakaway gap" noted in the 2/06/15 mid-day report (read here).
>>> FEATURED STOCK ARTICLE : Stalled Following "Breakaway Gap" 6 Weeks Ago - 3/19/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
NXPI
-
NASDAQ
Nxp Semiconductors N V
ELECTRONICS - Semiconductor - Broad Line
|
$104.04
|
-0.85
-0.81% |
$105.19
|
3,230,630
84.88% of 50 DAV
50 DAV is 3,806,000
|
$108.50
-4.11%
|
1/5/2015
|
$76.43
|
PP = $78.44
|
|
MB = $82.36
|
Most Recent Note - 3/23/2015 5:40:35 PM
G - Pulled back from its all-time high with below average volume behind today's loss while it finished at the session low. It is very extended from its prior base. Disciplined investors avoid chasing extended stocks.
>>> FEATURED STOCK ARTICLE : Very Extended Following Gap Up Gain on M&A News - 3/9/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
PANW
-
NYSE
Palo Alto Networks
Computer Sftwr-Security
|
$140.28
|
-1.04
-0.74% |
$143.40
|
1,015,765
76.89% of 50 DAV
50 DAV is 1,321,000
|
$149.35
-6.07%
|
7/30/2014
|
$84.21
|
PP = $85.88
|
|
MB = $90.17
|
Most Recent Note - 3/23/2015 5:35:10 PM
G - Its 50 DMA line and prior lows near $134 define important near-term support where subsequent violations may trigger technical sell signals. After breaking out 9/02/14 it has spent very little time basing, and it is very extended from any sound base, yet could produce more climactic gains.
>>> FEATURED STOCK ARTICLE : Fundamentals Improved But No New Base Has Formed - 3/12/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE
(%Change) |
Day High |
Volume
(% DAV)
(% 50 day avg vol) |
52 Wk Hi
% From Hi |
Featured
Date |
Price
Featured |
Pivot Featured |
|
Max Buy |
QLYS
-
NASDAQ
Qualys Inc
Computer Sftwr-Security
|
$44.43
|
-0.74
-1.64% |
$45.50
|
245,196
62.23% of 50 DAV
50 DAV is 394,000
|
$50.00
-11.14%
|
2/6/2015
|
$42.24
|
PP = $40.84
|
|
MB = $42.88
|
Most Recent Note - 3/23/2015 5:48:43 PM
G - Down with light volume behind today's 3rd consecutive loss. Consolidating above prior highs in the $40-41 area and its 50 DMA line which define important near-term support to watch.
>>> FEATURED STOCK ARTICLE : Consolidating Above Support at Prior Highs and 50-Day Moving Average - 3/20/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
REIS
-
NASDAQ
Reis Inc
Real Estate Dvlpmt/Ops
|
$26.22
|
-0.21
-0.79% |
$26.67
|
29,566
109.50% of 50 DAV
50 DAV is 27,000
|
$28.82
-9.02%
|
3/16/2015
|
$25.65
|
PP = $26.64
|
|
MB = $27.97
|
Most Recent Note - 3/24/2015 5:19:59 PM
Y - Holding its ground perched near its pivot point with no resistance remaining due to overhead supply. Gains above the pivot point must have at least +40% above average volume to trigger a convincing technical buy signal.
>>> FEATURED STOCK ARTICLE : Found Support at Long-Term Average and Fundamentals Are Good - 3/16/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
VRX
-
NYSE
Valeant Pharmaceuticals
DRUGS - Drug Manufacturers - Other
|
$203.11
|
-0.56
-0.27% |
$206.00
|
1,274,406
37.62% of 50 DAV
50 DAV is 3,388,000
|
$206.84
-1.80%
|
1/5/2015
|
$144.84
|
PP = $149.90
|
|
MB = $157.40
|
Most Recent Note - 3/24/2015 5:21:03 PM
G - Completed a new Public Offering on 3/17/15 while consolidating near its all-time high. Earnings for Dec '14 quarter raised concerns. Its 50 DMA line defines the closest support level to watch. See the latest FSU analysis for more details and new annotated graphs.
>>> FEATURED STOCK ARTICLE : Fundamental Concerns Raised by Weaker Earnings and Sales Increases - 3/24/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
|
|
|
THESE ARE NOT BUY RECOMMENDATIONS!
Comments contained in the body of this report are technical
opinions only. The material herein has been obtained
from sources believed to be reliable and accurate, however,
its accuracy and completeness cannot be guaranteed.
This site is not an investment advisor, hence it does
not endorse or recommend any securities or other investments.
Any recommendation contained in this report may not
be suitable for all investors and it is not to be deemed
an offer or solicitation on our part with respect to
the purchase or sale of any securities. All trademarks,
service marks and trade names appearing in this report
are the property of their respective owners, and are
likewise used for identification purposes only.
This report is a service available
only to active Paid Premium Members.
You may opt-out of receiving report notifications
at any time. Questions or comments may be submitted
by writing to Premium Membership Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 1-800-965-8307
or 954-785-1121.
|
|
|
